Wikidata

(Q61918139)

English

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

clinical trial

In more languages

Statements

title
A Randomized, Multinational, Double-Blind, Placebo-Controlled, Parallel-Group Design Pilot Study to Estimate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamic Effects of Teriflunomide for 24 Weeks When Added to Treatment With Interferon-beta in Subjects With Multiple Sclerosis. (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Sanofi
0 references
country
Canada
0 references
Germany
0 references
Italy
0 references
Spain
0 references
start time
May 2007
0 references
end time
June 2009
0 references
number of participants
118
0 references
research site
Sanofi
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918139&oldid=2109346636"